Diabetic retinopathy and diabetic neuropathy

Diabetes Care

Volumn 30, Issue 3, 2007, Pages 760-765

  Bloomgarden, Zachary T ^a,b  

^a Mount Sinai School of Medicine ^*

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CANDESARTAN; CARBAMAZEPINE; DULOXETINE; ERYTHROPOIETIN; FELBAMATE; FENOFIBRATE; GABAPENTIN; GROWTH HORMONE; IMIPRAMINE; LAMOTRIGINE; MORPHINE; OCTREOTIDE; PHENYTOIN; PLACEBO; PREGABALIN; RUBOXISTAURIN; SOMATOMEDIN C; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE;

ABDOMINAL PAIN; ANOREXIA; ATAXIA; CHOLELITHIASIS; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIARRHEA; DISEASE ASSOCIATION; DIZZINESS; ECG ABNORMALITY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LASER SURGERY; LEG BLOOD FLOW; MYALGIA; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; RETINA BLOOD VESSEL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; VITREOUS HEMORRHAGE; WEIGHT REDUCTION; XEROSTOMIA;

CERTIFICATION; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; HUMANS; NEWSPAPERS; UNITED STATES;

EID: 33847618400     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-zb03     Document Type: Review

References (45)

1. Koller EA, Green L, Gertner JM, Bost M, Malozowski SN: Retinal changes mimicking diabetic retinopathy in two nondiabetic, growth hormone-treated patients. J Clin Endocrinol Metab 83:2380-2383, 1998
2. Merimee TJ: A follow-up study of vascular disease in growth-hormone- deficient dwarfs with diabetes. N Engl J Med 298:1217-1222, 1978
3. Sharp PS, Fallon TJ, Brazier OJ, Sandler L, Joplin GF, Kohner EM: Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy. Diabetologia 30:199-207, 1987
4. Grant MB, Caballero S Jr: The potential role of octreotide in the treatment of diabetic retinopathy. Treat Endocrinol 4:199-203, 2005
5. Grant MB, Mames RN, Fitzgerald C, Hazariwala KM, Cooper-DeHoff R, Caballero S, Estes KS: The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care 23:504-509, 2000
6. Boehm BO, Lang GK, Jehle PM, Feldman B, Lang GE: Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy. Horm Metab Res 33:300-306, 2001
7. Hernaez-Ortega MC, Soto-Pedre E, Martin JJ: Sandostatin LAR for cystoid diabetic macular edema: a 1-year experience. Diabetes Res Clin Pract 64:71-72, 2004
8. Dornan TL, Carter RD, Bron AJ, Turner RC, Mann JI: Low density lipoprotein cholesterol: an association with the severity of diabetic retinopathy. Diabetologia 22:167-170, 1982
9. Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA: A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes 53:2883-2892, 2004
10. Banerjee S, Denniston AK, Gibson JM, Dodson PM: Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease? Eye 18:821-825, 2004
11. Gordon B, Chang S, Kavanagh M, Berrocal M, Yannuzzi L, Robertson C, Drexler A: The effects of lipid lowering on diabetic retinopathy. Am J Ophthalmol 112:385-391, 1991
12. Gupta A, Gupta V, Thapar S, Bhansali A: Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol 137:675-682, 2004
13. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH, CARDS Investigators: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685-696, 2004
14. Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesaniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M, FIELD Study Investigators: Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366:1849-1861, 2005
15. Gunn M: On ophthalmoscopic evidence of general arterial disease. Trans Ophthalmol Soc UK 18:356-381, 1898
16. Keith NM, Wagener HP, Barker NW: Some different types of essential hypertension: their course and prognosis. Am J Med Sci 197:332-343, 1939
17. Dimmitt SB, West JN, Eames SM, Gibson JM, Gosling P, Littler WA: Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet 1:1103-1106, 1989
18. Wong TY, Hubbard LD, Klein R, Marino EK, Kronmal R, Sharrett AR, Siscovick DS, Burke G, Tielsch JM: Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study. Br J Ophthalmol 86:1007-1013, 2002
19. Sharrett AR, Hubbard LD, Cooper LS, Sorlie PD, Brothers RJ, Nieto FJ, Pinsky JL, Klein R: Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 150:263-270, 1999
20. Wong TY, Klein R, Sharrett AR, Schmidt MI, Pankow JS, Couper DJ, Klein BE, Hubbard LD, Duncan BB, ARIC Investigators: Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 287:2528-2533, 2002
21. Klein R, Klein BE, Moss SE, Wong TY, Hubbard L, Cruickshanks KJ, Palta M: The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy. XIX. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 122:76-83, 2004
22. Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, Wofford MR, Sharrett AR: Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 358:1134-1140, 2001
23. Wong TY, Rosamond W, Chang PP, Couper DJ, Sharrett AR, Hubbard LD, Folsom AR, Klein R: Retinopathy and risk of congestive heart failure. JAMA 293:63-69, 2005
24. Klein BE, Klein R, McBride PE, Cruickshanks KJ, Palta M, Knudtson MD, Moss SE, Reinke JO: Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 164:1917-1924, 2004
25. Centers for Disease Control and Prevention (CDC): Correctable visual impairment among persons with diabetes: United States, 1999-2004. MMWR Morb Mortal Wkly Rep 55:1169-1172, 2006
26. PKC-DRS Study Group: The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKCDRS) multicenter randomized clinical trial. Diabetes 54:2188-2197, 2005
27. PKC-DRS2 Study Group: Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy. Ophthalmology 113:2221-2230, 2006
28. Tuttle KR, Bakris GL, Toto RD, McGill JB, Hu K, Anderson PW: The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care 28:2686-2690, 2005
29. Lilly announces FDA requirement of additional clinical trial before ruboxistaurin could be approved for treatment of diabetic retinopathy [article online]. Available from http://www.prnewswire.com/cgi-bin/micro_stories.pl? ACCT916306&TICK=LLY&STORY=/www/story/09-29-2006/0004442237&EDATE= Sep+29,+2006. Accessed 26 January 2007
30. Tesfaye S, Kempler P: Painful diabetic neuropathy. Diabetologia 48:805-807, 2005
31. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH, EURODIAB Prospective Complications Study Group: Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341-350, 2005
32. Vinik A: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab 90:4936-4945, 2005
33. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S: Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116:109-118, 2005
34. Raskin J, Wang F, Pritchett YL, Goldstein DJ: Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study. Pain Med 7:373-385, 2006
35. Rowbotham MC, Goli V, Kunz NR, Lei D: Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 110:697-706, 2004
36. Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS: Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 60:1284-1289, 2003
37. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M: Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115:254-263, 2005
38. Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE: Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 6:253-260, 2005
39. Frampton JE, Scott LJ: Pregabalin: in the treatment of painful diabetic peripheral neuropathy. Drugs 64:2813-2820, 2004
40. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U: Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110:628-638, 2004
41. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI, CAPSS-141 Study Group: Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 63:865-873, 2004
42. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL: Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352:1324-1334, 2005
43. Eaton SE, Harris ND, Rajbhandari SM, Greenwood P, Wilkinson ID, Ward JD, Griffiths PD, Tesfaye S: Spinal-cord involvement in diabetic peripheral neuropathy. Lancet 358:35-36, 2001
44. Selvarajah D, Wilkinson ID, Emery CJ, Harris ND, Shaw PJ, Witte DR, Griffiths PD, Tesfaye S: Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care 29:2664-2669, 2006
45. Eaton SE, Harris ND, Ibrahim S, Patel KA, Selmi F, Radatz M, Ward JD, Tesfaye S: Increased sural nerve epineurial blood flow in human subjects with painful diabetic neuropathy. Diabetologia 46:934-939, 2003